Previous close | 59.34 |
Open | 59.62 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 59.62 - 60.98 |
52-week range | 37.18 - 69.06 |
Volume | |
Avg. volume | 79 |
Market cap | 54.021M |
Beta (5Y monthly) | 1.54 |
PE ratio (TTM) | 0.02 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in Virtual KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024, which includes a presentation beginning at 12:45 pm ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the first quarter ended December 31, 2023.
Azenta, Inc. (Nasdaq: AZTA) today announced the launch of the BioArc™ Ultra (the "Ultra"), a breakthrough, automated solution for high-density, eco-friendly ultracold sample management, designed to provide a new level of performance for large-scale sample management with the potential to forever change the landscape of biorepositories. The Ultra delivers significant operational efficiency benefits, including footprint, labor and electricity cost savings as compared to other commercially availabl